Search results
What’s next for bird flu vaccines
Technology Review· 4 hours agoMost of the flu virus used in vaccines is grown in eggs, but there are alternatives. The seasonal flu vaccine Flucelvax, produced by CSL Seqirus, is grown in a cell line derived in the 1950s ...
What's Going On With Moderna Stock Today? - Moderna (NASDAQ:MRNA)
Benzinga· 3 days agoModerna Inc. MRNA shares are trading lower Tuesday. The stock may be pulling back after gaining on bird flu concerns last week and predictions for a slight rise in COVID-19 ...
Cathie Wood's ARK buys AMD, sells Moderna in latest stock trades By Investing.com
Investing.com· 2 days agoCathie Wood's ARK buys AMD, sells Moderna in latest stock trades
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 3 days agoModerna Inc (MRNA, Financial) recently experienced a significant daily loss of 7.74%, yet it boasts a 3-month gain of 72.72%. This analysis aims to explore Moderna ...
US Nears Deal to Fund Moderna's Bird Flu Vaccine Trial, FT Reports
US News & World Report· 1 day agoModerna and the U.S. Department of Health and Human Services (HHS) did not immediately respond to Reuters' requests for a comment. The United States, Canada and ...
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 4 days agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Thousands of NHS patients to trial new personalised cancer vaccine in ‘landmark moment’
The Independent via Yahoo News· 4 hours agoThe trial that Mr Pfebve took part in is one of several that will be taking place at NHS trusts...
The US is close to an agreement on funding for moderna bird flu vaccine trials, the FT reports
Weston Forum· 1 day agoThe Financial Times reported Thursday that the U.S. government is nearing a deal to fund late-stage...
Should You Buy This Stock After a Regulatory Setback? | The Motley Fool
The Motley Fool· 5 days agoThe past two-and-a-half years have been rough for Moderna (MRNA 1.58%). The company is developing...
...Invest Scoops Up Shares Of AMD And Palantir — Dumps Moderna Stock Worth $4.4M - ARK Genomic...
Benzinga· 2 days agoThese trades reflect Ark’s strategic adjustments amidst market movements. The AMD Trade Ark bought...
